Clinical Trials Browser

Imatinib Mesylate × Dermatologic × 90 days × Clear all

NCT04598009 2026-06-04

Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma

Phase 2 Recruiting

Melanoma